Page 12 - புதியது ஹாம்ப்ஷயர் தேசிய காவலர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Moderna begins COVID-19 vaccine trial for young children Moderna said it is expected to enroll 6,750 children from the U.S. and Canada less than 12 years old for this stage of the study. Author: Erin McHugh Updated: 7:12 AM MDT March 16, 2021 WASHINGTON Drugmaker Moderna announced on Tuesday it has kicked off a mid-to-late stage COVID-19 vaccine trial for children under the age of 12. The company said in a press release that the first participants in its Phase 2/3 study, called the KidCOVE study, have been given their first dose. The goal is to test if the vaccine candidate would protect children ages 6 months to less than 12 years from getting sick with COVID-19.

United statesUnited kingdomCharles krupaCenters for diseaseJohns hopkins universityBiomedical advanced researchNational institute of allergyDrug administrationDevelopment authorityHigh schoolEuropean unionHampshire national guardDrugmaker modernaNational instituteInfectious diseasesChief executive officer